ArticlePloS one2025
Extended spectrum β-lactamase (ESβL)-producing E. coli causing urinary tract infection among pregnant women and pediatric patients in public hospitals in northern Jordan.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Multidrug-resistant uropathogens in pediatric urinary tract infections: a multicenter retrospective trend analysis (2020-2024).Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
- Urinary tract infection among primigravid singleton pregnancies: a retrospective study from the North of Jordan.Frontiers in global women's health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUrinary tract infections (UTI's) imply the invasion and multiplication of bacteria in the individual's urinary tract, the incidence of UTI's is mainly determined by sex and age being the highest in pregnant females. E. coli is the most frequently encountered causative agent of UTI's and recent data depict an increase in antimicrobial resistance.
objectivesThis study aims to identify the most common pathogens associated with UTI's in pregnant women and children and to reveal the resistance patterns, and effective treatments and to detect resistance genes in E. coli.
methodsThis study was conducted in public-teaching Hospitals in northern Jordan during the period from the 1st of March 2024 to the 5th of April 2024. Urine samples were collected in a sterile urine container or using a special tube for pediatric samples. Each sample was cultivated on MacConkey, blood and mannitol salt agar plates, all plates were incubated aerobically at 37°C for 24 hours and identified using standard microbiological protocols. All isolates were tested for antimicrobial susceptibility. Polymerase chain reaction was performed to confirm all E. coli isolates by the detection of universal stress protein (uspA) gene and to detect ESβL genes TEM, SHV CTX-M.
resultsEight bacterial species were identified, 75% (6/8) Gram Negative, 25% (2/8) Gram Positive). Escherichia coli was the most frequently isolated species 71.4% (50/70) followed by Klebsiella pneumoniae 10% (7/70), Enterobacter cloacae 5.7% (4/70, Proteus mirabilis 4.3% (3/70), Enterococcus faecalis 2.9% (3/70), Acinetobacter baumannii 2.9% (3/70), Lelliottia amnigena 1.4% (1/70) and Streptococcus agalactiae 1.4% (1/70). All 50 biochemically confirmed E. coli isolates were also confirmed using uspA gene. Three resistance genes TEM, SHV and CTX-M were detected using polymerase chain reaction.
conclusionE. coli was the most frequently isolated species followed by K. pneumoniae, this result may indicate that K. pneumoniae is becoming increasingly common as an etiological agent of UTI. A high resistance toward Amoxicillin- Clavulanic Acid was found among E. coli isolates, while multiple antibiotic/drug resistance was 62%. These results highlight the need to adhere to the therapeutic guidelines in treating UTI's and other infections and not overuse antibiotics to prevent the emergence of multidrug-resistant bacteria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.